Tunitas Therapeutics Garners $10,000,000 Series A Financing Round

  • Feed Type
  • Date
  • Company Name
    Tunitas Therapeutics
  • Mailing Address
    409 Illinois Street San Francisco, CA 94158 USA
  • Company Description
    Tunitas Therapeutics is a biopharmaceutical company that is developing novel and precisely targeted protein therapeutics with the potential to dramatically change the lives of allergy sufferers.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    The funding will also be used to continue the development of Tunitas’ pipeline of novel targeted vaccines for the treatment of specific allergies.
  • M&A Terms
  • Venture Investor
    Ally Bridge Group
  • Venture Investor
    WuXi PharmaTech

Trending on Xconomy